InvestorsHub Logo

crudeoil24

01/10/22 4:17 PM

#2 RE: crudeoil24 #1

Molecular Partners shares are trading higher after the company, and Novartis, reported topline data from the Phase 2 study for ensovibep, a DARPin antiviral therapeutic for COVID-19.